Brief: Acer Therapeutics Filed Supplement Relating To Offer, Sale From Time To Time, With Aggregate Offering Price Of Up To $6.4 Million Shares Of Common Stock
17/05/2022 21:57
May 17 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS -FILED SUPPLEMENT RELATING TO OFFER,
SALE FROM
TIME TO TIME, WITH AGGREGATE OFFERING PRICE OF UP TO $6.4
MILLION SHARES OF COMMON STOCK
Source text for Eikon: ID:
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31